Evaluation of High Cholesterol and Risk of Dementia and Cognitive Decline in Older Adults Using Individual Patient Meta-Analysis.
Level 3 - non-randomized controlled study
Individual participant data meta-analysis of observational cohort studies
PubMed 34700321 · doi:10.1159/000519452
What was done
A two-stage individual participant data (IPD) meta-analysis harmonized data from 8 studies including over 21,000 participants aged 60 years and older (mean age 76 years). The authors evaluated associations between total, HDL, and LDL cholesterol (per mmol/L increase) and the risk of subsequent incident dementia or cognitive decline (assessed via a reliable change index method). Analyses were also stratified by statin use and APOE ε4 carrier status.
What was found
No relationship was found between cholesterol levels and cognitive outcomes: - Total cholesterol and cognitive decline: OR 0.93 (95% CI 0.86 to 1.01). - Total cholesterol and incident dementia: OR 1.01 (95% CI 0.89 to 1.13). - HDL and LDL cholesterol also showed no relationship with risk of cognitive decline (point estimates not provided in the abstract). - Stratification by statin use or APOE ε4 carrier status did not alter the results.
Why it matters
This IPD meta-analysis demonstrates that cholesterol levels measured in late life do not reliably predict subsequent cognitive decline or incident dementia, suggesting that late-life lipid profiles alone are not informative prognostic targets for dementia risk.
Limits
The study is restricted to older adults (mean age 76), precluding assessment of mid-life cholesterol exposure. As a synthesis of observational studies, residual confounding cannot be excluded. Specific risk estimates and confidence intervals for HDL and LDL cholesterol, as well as exact follow-up durations, were not reported in the abstract.
Cited by
- contradicts Failure to lower LDL cholesterol below 100 mg/dL or 70 mg/dL is associated with an increased risk of developing dementia.